Sinopharm
1099.HK
#2624
Rank
โ‚น630.36 B
Marketcap
โ‚น202.00
Share price
2.39%
Change (1 day)
-8.25%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2025: โ‚น7.788 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.788 Trillion. In 2025 the company made a revenue of โ‚น7.788 Trillion an increase over the revenue in the year 2024 that were of โ‚น7.586 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2025

Annual revenue

Year Revenue Change
2025โ‚น7.788 T2.65%
2024โ‚น7.586 T-5.1%
2023โ‚น7.994 T5.42%
2022โ‚น7.583 T-2.1%
2021โ‚น7.746 T16.85%
2020โ‚น6.629 T14.95%
2019โ‚น5.766 T21.52%
2018โ‚น4.745 T5.93%
2017โ‚น4.479 T27.22%
2016โ‚น3.521 T5.37%
2015โ‚น3.341 T9.14%
2014โ‚น3.061 T17.22%
2013โ‚น2.611 T25.94%
2012โ‚น2.073 T34.61%
2011โ‚น1.540 T55.34%
2010โ‚น991.84 B35.79%
2009โ‚น730.43 B37.56%
2008โ‚น531.00 B31.43%
2007โ‚น404.03 B40.26%
2006โ‚น288.05 B